Literature DB >> 11790126

Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.

Yoshihisa Hagihara1, Dong-Pyo Hong, Masaru Hoshino, Kei-ichi Enjyoji, Hisao Kato, Yuji Goto.   

Abstract

beta(2)-Glycoprotein I (beta(2)-GPI) is a plasma protein that binds to negatively charged substances such as DNA, heparin, and anionic phospholipids. The interaction of beta(2)-GPI with anionic phospholipids is intriguing in the context of the autoimmune disease antiphospholipid syndrome. To extend understanding of the binding mechanism to phospholipids, the interactions of beta(2)-GPI with amphiphiles, i.e., sodium lauryl sulfate and lysophospholipids, were examined. These amphiphiles induced the aggregation of beta(2)-GPI below the critical micelle concentration, indicating that the interaction of beta(2)-GPI with monodispersed amphiphiles is unstable, resulting in the formation of large aggregates. However, highly soluble monocaproylphosphatidic acid did not induce aggregation, suggesting that the hydrophobicity of the acyl chain is also an important factor for aggregate formation in addition to negative charges in the headgroup. A series of experiments using deletion mutants and a peptide showed that the fifth domain of beta(2)-GPI (domain V) is responsible for formation of aggregates observed for intact full-length beta(2)-GPI. In addition, the flexible loop (F307-C326) in the C-terminal of domain V, which consists of hydrophobic and positively charged residues, was identified as the important region for aggregation. These results indicate that beta(2)-GPI binds to the amphiphiles through the flexible loop of domain V, resulting in formation of large aggregates where both electrostatic and hydrophobic interactions are involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790126     DOI: 10.1021/bi015693q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.

Authors:  Roland Gamsjaeger; Alexander Johs; Anna Gries; Hermann J Gruber; Christoph Romanin; Ruth Prassl; Peter Hinterdorfer
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 2.  β-Amyloid aggregation and heterogeneous nucleation.

Authors:  Atul K Srivastava; Jay M Pittman; Jonathan Zerweck; Bharat S Venkata; Patrick C Moore; Joseph R Sachleben; Stephen C Meredith
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

Review 3.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

4.  Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.

Authors:  Daria Maria Monti; Fulvio Guglielmi; Maria Monti; Flora Cozzolino; Silvia Torrassa; Annalisa Relini; Piero Pucci; Angela Arciello; Renata Piccoli
Journal:  Eur Biophys J       Date:  2010-02-25       Impact factor: 1.733

5.  Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.

Authors:  Sherry D Fleming; Michael R Pope; Sara M Hoffman; Tiffany Moses; Urska Bukovnik; John M Tomich; Lynn M Wagner; Keith M Woods
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

6.  Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation.

Authors:  Maurizio Tomasi; Yasuaki Hiromasa; Michael R Pope; Sushanth Gudlur; John M Tomich; Sherry D Fleming
Journal:  Mol Immunol       Date:  2012-06-27       Impact factor: 4.407

7.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

8.  Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.

Authors:  Amit Kumar; Rebekah L Bullard; Pritesh Patel; Lea C Paslay; Dipti Singh; Ewa A Bienkiewicz; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

9.  SDS can be utilized as an amyloid inducer: a case study on diverse proteins.

Authors:  Javed Masood Khan; Atiyatul Qadeer; Sumit Kumar Chaturvedi; Ejaz Ahmad; Syed Arif Abdul Rehman; Samudrala Gourinath; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

10.  Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite.

Authors:  Carina C Clingman; Laura M Deveau; Samantha A Hay; Ryan M Genga; Shivender M D Shandilya; Francesca Massi; Sean P Ryder
Journal:  Elife       Date:  2014-06-16       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.